CAAPX | VMVAX | CAAPX / VMVAX | |
Total Expense Ratio | 1.14 | 0.07 | 1,629% |
Annual Report Gross Expense Ratio | 1.14 | 0.07 | 1,629% |
Fund Existence | 36 years | 14 years | - |
Gain YTD | 8.418 | 7.586 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 917M | 31B | 3% |
Annual Yield % from dividends | 0.40 | 2.22 | 18% |
Returns for 1 year | 4.23 | 8.36 | 51% |
Returns for 3 years | 3.99 | 24.75 | 16% |
Returns for 5 years | 12.63 | 72.25 | 17% |
Returns for 10 years | -6.60 | 114.57 | -6% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFAC | 37.79 | 0.74 | +2.00% |
Dimensional US Core Equity 2 ETF | |||
WLDR | 34.94 | 0.61 | +1.77% |
Affinity World Leaders Equity ETF | |||
UJAN | 41.48 | 0.28 | +0.67% |
Innovator US Equity Ultra Buff ETF™ Jan | |||
PBFR | 28.22 | 0.17 | +0.60% |
PGIM Laddered S&P 500 Buffer 20 ETF | |||
PCRB | 48.98 | 0.18 | +0.36% |
Putnam ESG Core Bond ETF |